Table of Contents

Hypoxic Tumors and Their Effect on Immune Cells and Cancer Therapy.- Characterization of Regulatory T Cells in Tumor Suppressive Microenvironments.- Generation of Cytotoxic T Lymphocytes for Immunotherapy of EBV-Associated Malignancies.- Acquisition, Preparation, and Functional Assessment of Human NK Cells for Adoptive Immunotherapy.- Enhanced Migration of Human Dendritic Cells Expressing Inducible CD40.- Differentiation of Human Embryonic Stem Cells into Hematopoietic Cells In Vitro.- Gene Therapy to Improve Migration of T Cells to the Tumor Site.- Gene Therapy to Improve Function of T Cells for Adoptive Immunotherapy.- Cytokine-FC Fusion Genes as Molecular Adjuvants for DNA Vaccines.- Pharmacology of Anti-CD3 Diphtheria Immunotoxin in CD3 Positive T-Cell Lymphoma Trials.- Construction of Human Antibody Gene Libraries and Selection of Antibodies by Phage Display.- Identification of Immunogenic Peptides of the Self-Tumor Antigen: Our Experience with Telomerase Reverse Transcriptase.- Rescue, Amplification, Purification, and PEGylation of Replication Defective First-Generation Adenoviral Vectors.- Adenovirus-Mediated Interleukin (IL)-24 Immunotherapy for Cancer.- Liposomes for Gene Transfer in Cancer Therapy.- Oncolytic HSV as a Vector in Cancer Immunotherapy.- Generation of Chimeric T-Cell Receptor Transgenes and Their Efficient Transfer in Primary Mouse T Lymphocytes.- Multi-walled Carbon Nanotube (MWCNT) Synthesis, Preparation, Labeling, and Functionalization.- Cellular Immunotherapy of Cancer.

Reviews

From the reviews:“17 chapters devoted to techniques and their application to the treatment of cancer as well as two general overviews. … Both trainees and experts in basic and clinical science who wish to undertake studies involving immunotherapy are the intended audience. It would be useful for those who are not familiar with what immunotherapeutic procedures actually involve. … The book is well put together and offers a lot of information that would be helpful to someone about to embark on developing immunotherapeutic treatments for cancer.” (Marion C. Cohen, Doody’s Review Service, March, 2011)